Press "esc" to clear
Go to Advanced Search
Showing results 3212132130 of 33444

Article ID: 606828

Lower-Cost Drug Substitutions Could Mean Big Savings for Medicare Patients, Government

University of California, Los Angeles (UCLA), Health Sciences

A new study points to a simple solution to the high cost of medications that could result in hundreds of dollars in savings per patient: Instead of brand-name drugs, substitute less expensive counterparts that have a similar therapeutic effect .

Released:
21-Aug-2013 7:00 PM EDT
Wise1crop.jpg
  • Embargo expired:
    21-Aug-2013 5:00 PM EDT

Article ID: 606057

Pop! Bursting the Bubble on Carbonation

Monell Chemical Senses Center

New research from the Monell Center reveals that bubbles are not necessary to experience the unique ‘bite’ of carbonated beverages, which actually comes from carbonic acid. Bubbles do, however, enhance carbonation’s bite through the light physical feel of the bubbles picked up by our sense of touch.

Released:
15-Aug-2013 10:00 AM EDT
sandborn_082113.jpg
  • Embargo expired:
    21-Aug-2013 5:00 PM EDT

Article ID: 606652

Potential New Drug for Inflammatory Bowel Disease

University of California San Diego Health

Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn’s disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The findings, published in two papers, will appear in the August 22 issue of the New England Journal of Medicine (NEJM).

Released:
16-Aug-2013 11:00 AM EDT
  • Embargo expired:
    21-Aug-2013 5:00 PM EDT

Article ID: 606696

Insecticide-Treated Bed Nets Critical to Global Elimination of Filariasis

Case Western Reserve University

An international team of scientists have demonstrated that a simple, low-cost intervention holds the potential to eradicate a debilitating tropical disease that threatens nearly 1.4 billion people in more than six dozen countries.

Released:
19-Aug-2013 2:00 PM EDT
Toni_Choueiri_SOG_2527.jpg
  • Embargo expired:
    21-Aug-2013 5:00 PM EDT

Article ID: 606728

Pazopanib Shows Better Quality-of-Life in Advanced Kidney Cancer

Dana-Farber Cancer Institute

An international study led by Dana-Farber scientists found that the oral targeted drugs pazopanib (Votrient) and sunitinib (Sutent), approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability.

Released:
20-Aug-2013 11:00 AM EDT

Article ID: 606824

Trial Aims to Advance Prenatal Diagnosis of Genetic Defects

Columbia University Irving Medical Center

High-risk pregnant women are being recruited for a clinical trial that aims to give parents detailed information about genetic abnormalities found with the latest prenatal genetic testing, known as microarray.

Released:
21-Aug-2013 4:55 PM EDT

Article ID: 606820

Putting Sleep Disorders to Bed

McGill University

In a new study published in Neuron, researchers have identified how a fundamental biological process called protein synthesis is controlled within the body’s circadian clock — the internal mechanism that controls one’s daily rhythms. Their findings may help shed light on future treatments for disorders triggered by circadian clock dysfunction, including jet lag, shift work disorders, and chronic conditions like depression and Parkinson’s disease.

Released:
21-Aug-2013 4:20 PM EDT
  • Embargo expired:
    21-Aug-2013 4:00 PM EDT

Article ID: 606502

Disease Caused by Repeat Brain Trauma in Athletes May Affect Memory, Mood, Behavior

American Academy of Neurology (AAN)

New research suggests that chronic traumatic encephalopathy (CTE), a brain disease associated with repeat brain trauma including concussions in athletes, may affect people in two major ways: initially affecting behavior or mood or initially affecting memory and thinking abilities. The study appears in the August 21, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. CTE has been found in amateur and professional athletes, members of the military and others who experienced repeated head injuries, including concussions and subconcussive trauma.

Released:
13-Aug-2013 2:00 PM EDT
  • Embargo expired:
    21-Aug-2013 4:00 PM EDT

Article ID: 606790

Researchers Agree that Alzheimer’s Test Results Could be Released to Research Participants, if Guidance and Counseling in Place

Perelman School of Medicine at the University of Pennsylvania

A leading group of Alzheimer's researchers contends that, as biomarkers to detect signals of the disease improve at providing clinically meaningful information, researchers will need guidance on how to constructively disclose test results and track how disclosure impacts both patients and the data collected in research studies.

Released:
21-Aug-2013 11:00 AM EDT
  • Embargo expired:
    21-Aug-2013 4:00 PM EDT

Article ID: 606802

Antipsychotic Drug Use in Children for Mood/Behavior Disorders Increases Type 2 Diabetes Risk

Vanderbilt University Medical Center

Prescribing of “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows. Young people using medications like risperidone, quetiapine, aripiprazol and olanzapine led to a threefold increased risk of developing type 2 diabetes within the first year of taking the drug, according to the study published Aug. 21 in the journal JAMA Psychiatry.

Released:
21-Aug-2013 12:40 PM EDT

Showing results 3212132130 of 33444

Chat now!